Phoenix Group continues rise from flames of indebtedness
European pharmaceuticals distributor Phoenix Group has signed a new loan of €1.35bn as it continues to deleverage following a 2010 restructuring.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
